# Biomarker qualification and context of use

Source: https://onco.cc/terms/biomarker-qualification-context/  
OnCo record `biomarker-qualification-context` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A biomarker can be accepted for a specified role in drug development. That acceptance has a defined scope and does not approve every test that measures it.

## Summary

FDA biomarker qualification concerns a specified interpretation and context of use in medical product development. The agency explicitly distinguishes qualification of the biomarker from qualification of its measurement method. The biomarker, specimen source, measurable characteristic and analytic method belong in a complete description. A qualification claim should retain that scope rather than being treated as general diagnostic approval or proof of clinical utility for every use.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: biomarker context of use; FDA biomarker qualification

## Sources

- FDA: biomarkers, roles and qualification: https://www.fda.gov/drugs/biomarker-qualification-program/about-biomarkers-and-qualification

## Connected records

- terms: [Analytical versus clinical validation](https://onco.cc/terms/analytical-vs-clinical-validation/), [Biomarker](https://onco.cc/terms/biomarker/), [Evidence from measurement to patient benefit](https://onco.cc/terms/measurement-to-benefit-evidence/)

---
JSON: https://onco.cc/api/v1/entities/biomarker-qualification-context.json